Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoichi Aoki

Showing results (201-210 of 205) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 205 results.
Cancer Medicine|September 26, 2024
Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancerKosei Hasegawa, Shunji Takahashi, Kimio Ushijima, et al.
Japanese Journal of Clinical Oncology|August 8, 2022
Regional differences in human papillomavirus type 52 prevalence among Japanese women with cervical intraepithelial neoplasia†Iwao Kukimoto, Mamiko Onuki, Kasumi Yamamoto, et al.
International Journal of Clinical Oncology|November 12, 2010
Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 editionSatoru Nagase, Hidetaka Katabuchi, Masamichi Hiura, et al.
BMJ Open|June 14, 2022
Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb)Shintaro Maki, Hiroaki Tanaka, Sho Takakura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2021
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA)Junzo Hamanishi, Nobuhiro Takeshima, Noriyuki Katsumata, et al.
Pageof 21

Showing results (201-210 of 205) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 205 results.
Cancer Medicine|September 26, 2024
Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancerKosei Hasegawa, Shunji Takahashi, Kimio Ushijima, et al.
Japanese Journal of Clinical Oncology|August 8, 2022
Regional differences in human papillomavirus type 52 prevalence among Japanese women with cervical intraepithelial neoplasia†Iwao Kukimoto, Mamiko Onuki, Kasumi Yamamoto, et al.
International Journal of Clinical Oncology|November 12, 2010
Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 editionSatoru Nagase, Hidetaka Katabuchi, Masamichi Hiura, et al.
BMJ Open|June 14, 2022
Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb)Shintaro Maki, Hiroaki Tanaka, Sho Takakura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2021
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA)Junzo Hamanishi, Nobuhiro Takeshima, Noriyuki Katsumata, et al.
Pageof 21